Elevation of serum CXCL13 in SLE as well as in sepsis

Lupus

Volumn 20, Issue 5, 2011, Pages 507-511

  Schiffer, L ^a   Kielstein, J T ^a   Haubitz, M ^a   Luhrs H ^a   Witte, T ^a   Haller, H ^a   Kumpers P ^a   Schiffer, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

biomarker; CXCL13; sepsis; systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CXCL13 CHEMOKINE;

ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE THAWING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; SEPSIS; STORAGE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINE CXCL13; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN STABILITY; SEPSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79955542314     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310383301     Document Type: Article

References (16)

1. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 1998 ; 391: 799-803 (Pubitemid 28099679)
2. Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000 ; 192: 1545-1552
3. Vissers JL, Hartgers FC, Lindhout E, Figdor CG, Adema GJ. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur J Immunol. 2001 ; 31: 1544-1549 (Pubitemid 32454703)
4. Schiffer L, Bethunaickan R, Ramanujam M, et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008 ; 180: 1938-1947
5. Schiffer L, Kumpers P, Davalos-Misslitz AM, et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant. 2009 ; 24: 3708-3712
6. Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol. 2010 ; 30: 45-52
7. Lee HT, Shiao YM, Wu TH, et al. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol. 2010 ; 37: 45-52
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
10. Piette JC. Updating the American College of Rheumatology criteria for systemic lupus erythematosus: comment on the letter by Hochberg. Arthritis Rheum. 1998 ; 41: 751-751
11. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003 ; 31: 1250-1256 (Pubitemid 36444440)
12. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998 ; 26: 1793-1800 (Pubitemid 28527688)
13. Ishikawa S, Sato T, Abe M, et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med. 2001 ; 193: 1393-1402 (Pubitemid 32565968)
14. Perrier P, Martinez FO, Locati M, et al. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J Immunol. 2004 ; 172: 7031-7042 (Pubitemid 38669145)
15. Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 1814-1820
16. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol. 1993 ; 20: 815-821 (Pubitemid 23158475)